Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05267925 · ClinicalTrials.gov registry record · NA
CuraLin Herbal Supplement for Type 2 Diabetes
A NA study, sponsored by National University of Natural Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05267925 is a NA study that was terminated before completion, run by National University of Natural Medicine. The registered enrollment target is 1 participants.
The verdict
NCT05267925, a NA study, was terminated before completion, sponsored by National University of Natural Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to provide preliminary data necessary for a larger, controlled trial of CuraLin as a treatment option for T2DM. This study will also fill the gap in literature surrounding herbal medicine in the treatment of T2DM. The use of herbal preparations for diabetes has increased globally, and given the costs, adverse effects, lack of clinical outcome improvement, and minimal A1c reductions associated with medications, safer, more affordable alternatives need to be explored. CuraLin™ is a dietary supplement manufactured by NutraStar Inc. and sold by CuraLife; it is a blend of nine ayurvedic plants and herbs taken three times daily, after meals for the management of diabetes. It is hypothesized that CuraLin will be safely tolerated among adults with Type 2 Diabetes Mellitus, and will improve glucose control and cardiometabolic risk factors over this 12 week study.
Interventions
- DIETARY_SUPPLEMENT CuraLin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-01-08 |
| Est. Completion | 2022-04-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05267925
The ClinicalTrials.gov registry entry for NCT05267925 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National University of Natural Medicine, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CuraLin is the first listed.
NCT05267925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05267925 about?
NCT05267925 is a clinical study titled "CuraLin Herbal Supplement for Type 2 Diabetes". The purpose of this study is to provide preliminary data necessary for a larger, controlled trial of CuraLin as a treatment option for T2DM. This study will also fill the gap in literature surrounding herbal medicine in the treatment of T2DM. The use of herbal preparations for diabetes has increased...
What is the current status of trial NCT05267925?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-01-08. Estimated completion is 2022-04-14.
What interventions are being tested in trial NCT05267925?
The interventions under investigation include: CuraLin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05267925?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.